申请人:YOUDIM MOUSSA
公开号:US20120058945A1
公开(公告)日:2012-03-08
Novel iron chelators exhibiting neuroprotective and good transport properties are useful in iron chelation therapy for treatment of a disease, disorder or condition associated with iron overload and oxidative stress, e.g., a neurodegenerative or cerebrovascular disease or disorder, a neoplastic disease, hemochromatosis, thalassemia, a cardiovascular disease, diabetes, an inflammatory disorder, anthracycline cardiotoxicity, a viral infection, a protozoal infection, a yeast infection, retarding aging, and prevention and/or treatment of skin aging and skin protection against sunlight and/or UV light. The iron chelator function is provided by a 8-hydroxyquinoline, a hydroxypyridinone or a hydroxamate moiety. The neuroprotective function is imparted to the compound, e.g., by a neuroprotective peptide. A combined antiapoptotic and neuroprotective function is provided by a propargyl group.
表现出神经保护和良好输送特性的新型铁螯合剂,可用于治疗与铁过载和氧化应激相关的疾病、障碍或病况,例如神经退行性或脑血管疾病或障碍、肿瘤性疾病、血色病、地中海贫血、心血管疾病、糖尿病、炎症性疾病、蒽环类心肌毒性、病毒感染、原虫感染、酵母感染、延缓衰老以及预防和/或治疗皮肤老化和皮肤对阳光和/或紫外线的保护。铁螯合剂功能由8-羟基喹啉、羟基吡啶酮或羟肟酸基团提供。神经保护功能由神经保护肽等化合物赋予。丙炔基提供了联合抗凋亡和神经保护功能。